Analytical Data
-
Gene name
CD164
- Application
-
Alternative Names
CD164；Sialomucin core Protein 24
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q04900
-
Expression Region
24-162aa
-
AA Sequence
ADPDKNTTQH PNVTTLAPIS NVTSAPVTSL PLVTTPAPET CEGRNSCVSC FNVSVVNTTC FWIECKDESY CSHNSTVSDC QVGNTTDFCS VSTATPVPTA NSTAKPTVQP SPSTTSKTVT TSGTTNNTVT PTSQPVRKST FDHHHHHH
-
Molecular Weight
16 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CD164, also known as the myeloid-associated receptor, is a transmembrane sialomucin that plays a critical role in various biological processes, including cell adhesion, migration, and differentiation. It is primarily expressed in hematopoietic stem cells and plays a significant role in the regulation of immune responses. Recent studies have revealed that CD164 is implicated in several pathophysiological conditions, including cancer progression and inflammation, making it an attractive target for therapeutic interventions. The recombinant protein form of CD164 allows researchers to investigate its functions and interactions in a controlled environment. By utilizing recombinant technology, scientists can produce large quantities of CD164 for functional assays, structural studies, and potential therapeutic applications. Understanding the structure-function relationship of CD164 through these recombinant proteins may lead to novel insights into its role in immune modulation and tumor biology. Furthermore, studies involving CD164 can facilitate the development of targeted therapies that may improve treatment outcomes in hematological malignancies and other diseases associated with dysregulated CD164 activity. Thus, research on CD164 recombinant proteins is essential for uncovering its biological significance and potential as a therapeutic target in various diseases.
